Cosmo N.V.
5y streak
NL · Healthcare · Stock Cosmo N.V. is a Dutch-incorporated specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal diseases, with its primary operations conducted through its Irish subsidiary Cosmo Pharmaceuticals. The company is known for products such as Methylene Blue MMX for colorectal cancer detection and budesonide-based therapies for inflammatory bowel conditions. Cosmo also has a diagnostics and medical devices division and licenses several of its technologies to pharmaceutical partners globally.
Dividend Yield
—
TTM · SIX
Last Dividend
2.10
EUR · 2026-04-24
5Y Growth
—
CAGR
Frequency
Annual
Years Paid
5
consecutive
Not Cut
4
consecutive yrs
Grown
4
consecutive yrs
Listings
| Exchange | Ticker | Currency | Yield TTM |
|---|---|---|---|
| SIX primary | COPN | CHF | — |
Annual Dividends
Annual dividend per share · 7 years of data
Advertisement
Dividend Yield History
Dividend History
| Ex-Date ▼ | Pay-Date ▼ | Amount ▼ | Type ▼ |
|---|---|---|---|
| 24.04.2026 | 11.05.2026 | 2.10 EUR | Ordinary |
| 04.06.2025 | 06.06.2025 | 2.05 EUR | Ordinary |
| 10.07.2024 | 12.07.2024 | 2.00 EUR | Ordinary |
| 31.05.2023 | 02.06.2023 | 1.05 EUR | Ordinary |
| 01.06.2022 | 03.06.2022 | 0.95 EUR | Ordinary |
| 29.05.2017 | 31.05.2017 | 1.50 EUR | Ordinary |
| 01.09.2016 | 15.09.2016 | 1.40 EUR | Ordinary |